Shanghai Bio-heart Biological Technology Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Philip Wang
Chief executive officer
CN¥86.2m
Total compensation
| CEO salary percentage | 0.8% |
| CEO tenure | 9.4yrs |
| CEO ownership | 30.2% |
| Management average tenure | 3.5yrs |
| Board average tenure | 3.4yrs |
Recent management updates
Recent updates
Companies Like Shanghai Bio-heart Biological Technology (HKG:2185) Are In A Position To Invest In Growth
Feb 22
Companies Like Shanghai Bio-heart Biological Technology (HKG:2185) Are In A Position To Invest In Growth
Nov 03We Think Shanghai Bio-heart Biological Technology (HKG:2185) Can Afford To Drive Business Growth
May 12We're Not Worried About Shanghai Bio-heart Biological Technology's (HKG:2185) Cash Burn
Sep 19Shanghai Bio-heart Biological Technology (HKG:2185) Is In A Good Position To Deliver On Growth Plans
Jun 03CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -CN¥176m |
| Sep 30 2023 | n/a | n/a | -CN¥182m |
| Jun 30 2023 | n/a | n/a | -CN¥189m |
| Mar 31 2023 | n/a | n/a | -CN¥197m |
| Dec 31 2022 | CN¥86m | CN¥708k | -CN¥204m |
| Sep 30 2022 | n/a | n/a | -CN¥234m |
| Jun 30 2022 | n/a | n/a | -CN¥263m |
| Mar 31 2022 | n/a | n/a | -CN¥312m |
| Dec 31 2021 | CN¥192m | CN¥709k | -CN¥361m |
| Sep 30 2021 | n/a | n/a | -CN¥437m |
| Jun 30 2021 | n/a | n/a | -CN¥512m |
| Mar 31 2021 | n/a | n/a | -CN¥419m |
| Dec 31 2020 | CN¥61m | CN¥491k | -CN¥326m |
| Dec 31 2019 | CN¥418k | CN¥418k | -CN¥24m |
Compensation vs Market: Philip's total compensation ($USD11.91M) is above average for companies of similar size in the Hong Kong market ($USD233.89K).
Compensation vs Earnings: Philip's compensation has been consistent with company performance over the past year.
CEO
Philip Wang (55 yo)
9.4yrs
Tenure
CN¥86,203,000
Compensation
Mr. Li Wang, also known as Philip, serves as Executive Chairman of the Board, Chief Executive Officer and General Manager of Shanghai Bio-heart Biological Technology Co., Ltd. and was appointed as its Dire...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman of the Board | no data | CN¥86.20m | 30.24% CN¥ 151.6m | |
| CFO, Joint Company Secretary & Executive Director | 3.5yrs | CN¥12.89m | no data | |
| Financial Manager & Executive Director | 9.8yrs | CN¥4.44m | no data | |
| Chief Medical Officer | 3.2yrs | no data | no data | |
| Joint Company Secretary | 3.4yrs | no data | no data | |
| Supervisor & Head of Technology of BRS | no data | CN¥4.73m | no data |
3.5yrs
Average Tenure
38.5yo
Average Age
Experienced Management: 2185's management team is considered experienced (3.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman of the Board | 9.4yrs | CN¥86.20m | 30.24% CN¥ 151.6m | |
| CFO, Joint Company Secretary & Executive Director | 3.7yrs | CN¥12.89m | no data | |
| Financial Manager & Executive Director | 1.5yrs | CN¥4.44m | no data | |
| Supervisor & Head of Technology of BRS | 3.4yrs | CN¥4.73m | no data | |
| Independent Non-Executive Director | 3.5yrs | CN¥400.00k | no data | |
| Independent Non-Executive Director | 3.5yrs | CN¥400.00k | no data | |
| Suepervisor | 1.5yrs | no data | no data | |
| Independent Non-Executive Director | less than a year | no data | no data | |
| Employee Representative Supervisor | less than a year | no data | no data |
3.4yrs
Average Tenure
38.5yo
Average Age
Experienced Board: 2185's board of directors are considered experienced (3.4 years average tenure).